Market revenue in 2023 | USD 2,375.7 million |
Market revenue in 2030 | USD 3,868.7 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Plaque Modification Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 20.54% in 2024. Horizon Databook has segmented the Asia Pacific peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare industry in the Asia Pacific region has experienced noteworthy expansion, particularly in the market for peripheral vascular devices. These devices play a crucial role in treating conditions that impact blood vessels beyond the heart & brain, such as Peripheral Artery Disease (PAD), Deep Vein Thrombosis (DVT), and similar ailments.
Key players in the global peripheral vascular devices market, including Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cook Medical, and Terumo Corporation, dominate with a wide array of products and extensive distribution networks. Continuous innovation in product development is a crucial strategy for these companies, allowing them to gain a competitive edge.
For instance, in July 2023, the U.S. FDA recently issued revised guidance to healthcare practitioners regarding the utilization of paclitaxel-coated devices in managing PAD. This action followed the dissemination of a 2018 meta-analysis featured in the Journal of the American Heart Association, which identified an elevated risk of delayed mortality in individuals subjected to paclitaxel devices.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific peripheral vascular devices market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account